Brooks Laboratories Ltd. IPO

Brooks Laboratories Ltd. was established in 2002 and maintains its strong presence in the Pharmaceutical industry as a Contract Manufacturing Company since its inception. Brooks is a Research and Development driven Pharmaceutical manufacturing company, in last 5 years company has successfully established itself as a reputed Contract Manufacturing company for latest molecules in Injectables and Clavulanic Acid range in Tablets and Dry Syrups. Brooks Known for quality, products & commited service standards having capacity to manufacture 30 million injectables, 12 Million Dry Syrups and 120 million Clavulanic based tablates per annum At present, Brooks manufactures range of products on third party basis for companies like Zydus Cadila, Alembic, Intas, Wockhardt, Alkem, VHB, Medley, Biochem, JB Chemical, PDPL and Sanat etc.

The company have focused ourselves in developing a world class team to develop new molecules in injectables and clavulanic acid based products supported by sophisticated infrastructure for Research & Development. This facility, we are housing 16 scientists and research scholars. This team is working in development of latest broad spectrum antibiotics and other latest molecules. Process development is done in best possible ways

This modern and state of the art plant is located in Excise Free Zone. Where special tax advantages are bestowed by Center Government like 100 % Excise Exemption and State Government

The Indian pharmaceuticals industry is significantly developed in terms of infrastructure, technology and product range in recent years. The country now ranks among the top four worldwide accounting for 8% to 10% of world’s production by volume and 1.5% to 2% by value.

Company Promoters:

Mr. Atul Ranchal
Mr. Rajesh Mahajan

Issue Details :

IPO Subscription Detail / IPO Oversubscription Details / IPO Final Bidding Status

		Brooks Laboratories Ltd. IPO Allotment Status
		Brooks Laboratories Ltd. IPO Basis of Allotment